Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2416441)

  • 1. Tumor markers: value and limitations in the management of cancer patients.
    Bates SE; Longo DL
    Cancer Treat Rev; 1985 Sep; 12(3):163-207. PubMed ID: 2416441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytochemical evaluation of human esophageal neoplasms and preneoplastic lesions for beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
    Burg-Kurland CL; Purnell DM; Combs JW; Hillman EA; Harris CC; Trump BF
    Cancer Res; 1986 Jun; 46(6):2936-43. PubMed ID: 2421889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of five tumor markers (AFP, CEA, hCG, hPL and SP1) in monitoring therapy and follow-up of patients with testicular germ cell tumors.
    Szymendera JJ; Zborzil J; Sikorowa L; Leńko J; Kamińska JA; Gadek A
    Oncology; 1983; 40(1):1-10. PubMed ID: 6185897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour markers in urology: aids in cancer diagnosis and management.
    Wahren B
    Urol Res; 1979 Jun; 7(2):57-67. PubMed ID: 89748
    [No Abstract]   [Full Text] [Related]  

  • 5. Placental proteins as tumor markers.
    Braunstein GD
    Immunol Ser; 1990; 53():673-701. PubMed ID: 1713070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tumor markers].
    Cappelaere P
    Rev Prat; 1988 Jun; 38(17):1058-63. PubMed ID: 2457249
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumor markers in advanced nonseminomatous testicular cancer.
    Bosl GJ; Lange PH; Nochomovitz LE; Goldmann A; Fraley EE; Rosai J; Johnson K; Kennedy BJ
    Cancer; 1981 Feb; 47(3):572-6. PubMed ID: 6164464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tumor markers in gynecologic malignancies].
    Tojo S; Suzuki A; Fujii S; Ashitaka Y; Maruo T; Matsuura S
    Gan No Rinsho; 1983 May; 29(6):678-83. PubMed ID: 6192268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemistry of germ cell and trophoblastic neoplasms.
    Niehans GA; Manivel JC; Copland GT; Scheithauer BW; Wick MR
    Cancer; 1988 Sep; 62(6):1113-23. PubMed ID: 2457424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical significances of carcinoembryonic proteins in patients with ovarian carcinoma.
    Tottori K; Takeuchi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1981 Jan; 33(1):142-50. PubMed ID: 6164739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of serum tumor markers in cancer diagnosis and management.
    Bates SE; Longo DL
    Semin Oncol; 1987 Jun; 14(2):102-38. PubMed ID: 2438773
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumor-associated antigens in polyps and carcinoma of the human large bowel.
    Skinner JM; Whitehead R
    Cancer; 1981 Mar; 47(6):1241-5. PubMed ID: 6164469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preneoplasia and neoplasia of the bronchus, esophagus, and colon: the use of markers in determining phenotypes and classification.
    Trump BF; McDowell EM; Shamsuddin AK; Phelps PC; Purnell DM; Wilson TS; Banks-Schlegel SP; Kurland CL; Harris CC
    Monogr Pathol; 1985; (26):101-39. PubMed ID: 2414648
    [No Abstract]   [Full Text] [Related]  

  • 14. Value of five tumor markers (AFP, CEA, hCG, hPL and SP1) in diagnosis and staging of testicular germ cell tumors.
    Szymendera JJ; Zborzil J; Sikorowa L; Kamińska JA; Gadek A
    Oncology; 1981; 38(4):222-9. PubMed ID: 6165945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sense and nonsense of tumor markers in practice].
    Joss R; Cerny T
    Schweiz Med Wochenschr; 1990 May; 120(19):693-703. PubMed ID: 1693445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum tumor markers in patients with metastatic germ cell tumors of the testis. A 10-year experience.
    Bosl GJ; Geller NL; Cirrincione C; Nisselbaum J; Vugrin D; Whitmore WF; Golbey RB
    Am J Med; 1983 Jul; 75(1):29-35. PubMed ID: 6190398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Placental and embryonal proteins as antigens in the immunodiagnosis of malignant tumors].
    Tatarinov IuS
    Vestn Akad Med Nauk SSSR; 1977; (10):90-3. PubMed ID: 72463
    [No Abstract]   [Full Text] [Related]  

  • 18. Localization of alpha-fetoprotein and human chorionic gonadotropin to specific histologic types of nonseminomatous testicular cancer.
    Fowler JE; Sesterhenn I; Stutzman RE; Mostofi FK
    Urology; 1983 Dec; 22(6):649-54. PubMed ID: 6196899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum tumor markers.
    Perkins GL; Slater ED; Sanders GK; Prichard JG
    Am Fam Physician; 2003 Sep; 68(6):1075-82. PubMed ID: 14524394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical markers in the plasma and tumors of patients with gynecologic malignancies.
    van Nagell JR; Donaldson ES; Hanson MB; Gay EC; Pavlik EJ
    Cancer; 1981 Jul; 48(2 Suppl):495-503. PubMed ID: 6168368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.